Folate status, genomic DNA hypomethylation, and risk of colorectal adenoma and cancer: a case control study

• Published in: Gastroenterology (New York, N.Y. 1943) Vol. 124; no. 5; p. 1240
• Main Authors: Pufulete, Maria, Al-Ghnaniem, Reyad, Leather, Andrew J M, Appleby, Paul, Gout, Sally, Terry, Catherine, Emery, Peter W, Sanders, Thomas A B
• Format: Journal Article
• Language: English
• Published: United States 01.05.2003
• Subjects: Adenoma - blood; Adenoma - epidemiology; Adenoma - genetics; Aged; Case-Control Studies; Colorectal Neoplasms - blood; Colorectal Neoplasms - epidemiology; Colorectal Neoplasms - genetics; DNA Methylation; Female; Folic Acid - blood; Gene Frequency; Genetic Predisposition to Disease - epidemiology; Genotype; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors - genetics; Polymorphism, Genetic; Risk Factors
• ISSN: 0016-5085
• DOI: 10.1016/S0016-5085(03)00279-8

Low folate intake may increase risk for colorectal cancer by inducing DNA hypomethylation. This study reports the influence of folate status, DNA methylation, and polymorphisms of methylenetetrahydrofolate reductase (MTHFR 677C-->T and 1298A-->C), methionine synthase (MS 2756A-->G), and cystathionine-beta-synthase (CBS 844ins68) on risk for developing colorectal neoplasia. Thirty-five patients with adenoma, 28 patients with cancer, and 76 controls were recruited for a case control study. Recruitment consent rate was 98%. Blood samples were obtained for determination of blood folates, vitamin B(12), homocysteine, DNA methylation, and genotypes. Tissue biopsy samples were obtained at colonoscopy for determination of DNA methylation in colonic mucosa. Folate status was assessed by constructing a score from estimates of dietary intake and serum and erythrocyte folate. Cancer patients had 26% lower folate status (95% confidence interval [CI]: 6% to 44%, P = 0.01) and 21% lower serum vitamin B(12) concentration (95% CI: -38% to 1%, P = 0.06) compared with controls. [(3)H] methyl incorporation into colonic DNA was 26% higher in patients with adenoma (95% CI: 8% to 56%, P = 0.009) and 30% higher in patients with cancer (95% CI: -3% to 48%, P = 0.08) compared with controls. High folate status was associated with decreased risk for cancer (P = 0.01 for trend). Colonic and leukocyte DNA hypomethylation were associated with increased risk for adenoma (P = 0.02 and P = 0.01 for trend, respectively) and a nonsignificantly increased risk for cancer (P = 0.09 and P = 0.08 for trend, respectively). Low folate status and DNA hypomethylation are associated with colorectal neoplasia.